LUPINI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 4.793
AS - Asia 2.344
EU - Europa 1.777
SA - Sud America 305
Continente sconosciuto - Info sul continente non disponibili 105
AF - Africa 51
OC - Oceania 3
Totale 9.378
Nazione #
US - Stati Uniti d'America 4.662
SG - Singapore 876
CN - Cina 567
IT - Italia 411
DE - Germania 294
VN - Vietnam 281
PL - Polonia 273
BR - Brasile 227
FI - Finlandia 189
HK - Hong Kong 174
GB - Regno Unito 155
TR - Turchia 132
UA - Ucraina 103
CA - Canada 69
SE - Svezia 67
FR - Francia 62
BD - Bangladesh 56
IN - India 53
JP - Giappone 49
ID - Indonesia 44
MX - Messico 43
RU - Federazione Russa 43
NL - Olanda 33
BE - Belgio 31
AR - Argentina 27
RO - Romania 21
CZ - Repubblica Ceca 19
ZA - Sudafrica 19
IQ - Iraq 18
AT - Austria 16
ES - Italia 15
LT - Lituania 12
PK - Pakistan 12
CO - Colombia 11
IE - Irlanda 10
CL - Cile 9
EC - Ecuador 9
TN - Tunisia 9
EG - Egitto 8
VE - Venezuela 8
IR - Iran 7
MY - Malesia 7
PH - Filippine 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
PE - Perù 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
DZ - Algeria 5
KZ - Kazakistan 5
OM - Oman 5
AL - Albania 4
CR - Costa Rica 4
JM - Giamaica 4
JO - Giordania 4
NP - Nepal 4
AU - Australia 3
GR - Grecia 3
KE - Kenya 3
LV - Lettonia 3
MA - Marocco 3
TW - Taiwan 3
BH - Bahrain 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
IL - Israele 2
KR - Corea 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
NO - Norvegia 2
PA - Panama 2
PY - Paraguay 2
QA - Qatar 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GD - Grenada 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KH - Cambogia 1
LB - Libano 1
LU - Lussemburgo 1
MN - Mongolia 1
MQ - Martinica 1
MT - Malta 1
PS - Palestinian Territory 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 9.272
Città #
Ashburn 609
Singapore 522
Fairfield 430
Woodbridge 349
San Jose 334
Warsaw 271
Houston 229
Ann Arbor 223
Beijing 212
Chandler 203
Santa Clara 181
Seattle 178
Hong Kong 173
Munich 171
Cambridge 135
Wilmington 128
Jacksonville 126
New York 117
Ferrara 114
Helsinki 113
Dallas 109
Ho Chi Minh City 95
Los Angeles 76
Izmir 66
Milan 58
Council Bluffs 56
Hanoi 53
Tokyo 49
Turku 47
Shanghai 46
Nanjing 45
Princeton 37
Jakarta 36
Orem 36
Lauterbourg 34
Brussels 31
London 28
Mexico City 27
San Diego 27
Buffalo 26
Boardman 25
Chicago 24
Tianjin 23
São Paulo 22
Nanchang 21
Rome 21
Toronto 21
Atlanta 20
Montreal 20
Bologna 19
Bremen 19
Phoenix 19
Addison 17
Da Nang 17
Denver 17
Timisoara 17
Brooklyn 16
Falls Church 16
Amsterdam 14
Chennai 14
Johannesburg 14
Brno 13
Dong Ket 13
Shenyang 13
The Dalles 13
Changsha 12
Haiphong 12
Nuremberg 12
Manchester 11
Stockholm 11
Boston 10
Dublin 10
Poplar 10
Redwood City 10
Rio de Janeiro 10
Dearborn 9
Hebei 9
Moscow 9
San Francisco 9
Washington 9
Barnet 8
Columbus 8
Frankfurt am Main 8
Kunming 8
Charlotte 7
Naples 7
Philadelphia 7
Santiago 7
Ankara 6
Auburn Hills 6
Baghdad 6
Belo Horizonte 6
Falkenstein 6
Hangzhou 6
Hefei 6
Jiaxing 6
Mountain View 6
Salt Lake City 6
Tampa 6
Vienna 6
Totale 6.533
Nome #
Absolute quantification of cell-free microRNAs in cancer patients 337
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 316
A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma 311
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 304
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy 303
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 298
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 278
Ruolo del miR-221 nella tumorigenesi epatica 277
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 274
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 271
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 265
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 254
Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25 249
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 247
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 244
Circulating non-coding RNA as biomarkers in colorectal cancer 240
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 236
HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights 235
Quantification of circulating miRNAs by droplet digital PCR: Comparison of EvaGreen- and TaqMan-based chemistries 231
Circulating microRNA quantification using DNA-binding dye chemistry and droplet digital PCR 224
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 223
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 218
Estrogen receptor mutation: a new strategy to overcome endocrine resistance 215
Circulating tumor DNAs and non-coding RNAs as potential biomarkers for hepatocellular carcinoma diagnosis, prognosis and response to therapy 214
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 207
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 207
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer 195
Molecular biomarkers predicting early development of endometrial carcinoma: A pilot study 190
Mutated beta-catenin evades a microRNA-dependent regulatory loop 189
MiR-145 participates with TP53 in a death promoting regulatory loop and targets estrogen receptor in human breast cancer cells 184
Inhibiting the oncogenic mir-221 by microRNA sponge: Toward microRNA-based therapeutics for hepatocellular carcinoma 174
Oncogenic role of miR-483-3p at the IGF2/483 locus 173
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 172
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 171
Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients 169
MicroRNA Expression Profiling and Its Clinical Impact in Breast Cancer 165
The importance of microRNAs in RAS oncogenic activation in human cancer 155
Microbiota and environmental health monitoring of mouse colonies by metagenomic shotgun sequencing 142
Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy 138
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs 132
How to fish a good micro-marker out from a worthless lake: The case of cell-free miR-181a-5p and breast cancer 122
null 89
null 77
null 63
Totale 9.378
Categoria #
all - tutte 40.438
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.731
Totale 42.169


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022428 0 30 30 23 23 23 45 24 16 33 53 128
2022/2023474 48 41 29 67 66 72 35 31 52 2 17 14
2023/2024332 28 36 11 5 31 85 16 28 7 8 5 72
2024/20251.520 35 35 95 78 147 171 93 69 309 114 183 191
2025/20263.580 389 135 267 394 502 242 488 220 386 323 168 66
2026/2027113 89 24 0 0 0 0 0 0 0 0 0 0
Totale 9.378